Even though Wal-Mart shares are continuing to move higher, you can still get in now, Cramer said today on Stop Trading! But he isn’t a fan of the retailer's plan to spin off Sam’s Club. There’s no reason for Sam’s Club to IPO, he said, because it’s a “good adjunct” to the rest of Wal-Mart.
Cramer also said Celgene was “a great buy here.” At the American Society of Clinical Oncology Conference in Chicago this weekend, Celgene made a “major statement” about its cancer drug, Revlimid, which “just got ignored.” The stock has been on a tear for the past year, but Cramer thinks Revlimid gives it even more room for upside.
And Cramer said a Bear Stearns analyst upgrade of Sirius is a “big call.” Even though the stock is down today, Cramer said it has the chance to hit the analyst's $4 price target. Cramer has been bearish on both Sirius and XM Satellite Radio for a while, saying he thinks the only chance either company has of surviving is if they get clearance to merge.
Questions? Comments? firstname.lastname@example.org